2021
DOI: 10.1038/s41598-021-88257-w
|View full text |Cite
|
Sign up to set email alerts
|

Pre-existing and machine learning-based models for cardiovascular risk prediction

Abstract: Predicting the risk of cardiovascular disease is the key to primary prevention. Machine learning has attracted attention in analyzing increasingly large, complex healthcare data. We assessed discrimination and calibration of pre-existing cardiovascular risk prediction models and developed machine learning-based prediction algorithms. This study included 222,998 Korean adults aged 40–79 years, naïve to lipid-lowering therapy, had no history of cardiovascular disease. Pre-existing models showed moderate to good … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
25
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(26 citation statements)
references
References 44 publications
1
25
0
Order By: Relevance
“…Machine learning–based models including logistic regression, treebag, support vector machine, random forest, adaboost and the neural network model show high C-statistic values and have been used to produce prediction algorithms, especially in cardiovascular risk prediction. [ 24 ]…”
Section: Improving the Biomarker And Rpm-related Research Outputmentioning
confidence: 99%
“…Machine learning–based models including logistic regression, treebag, support vector machine, random forest, adaboost and the neural network model show high C-statistic values and have been used to produce prediction algorithms, especially in cardiovascular risk prediction. [ 24 ]…”
Section: Improving the Biomarker And Rpm-related Research Outputmentioning
confidence: 99%
“…We anticipate that not all biomarkers from each domain will be needed, but that a parsimonious set of biomarkers from multiple modalities may improve predictive accuracy. The overall result will be a predictive risk score for TIPN that can be used to classify patients as low, moderate, or high risk to guide clinical management, 104,106 based on extent of impacts on physical functioning and likelihood of treatment discontinuation.…”
Section: Statistical Analysesmentioning
confidence: 99%
“…SNGAN+DGflow (Ansari et al, 2020) 9.62 AutoGAN (Gong et al, 2019) 12.4 TransGAN (Jiang et al, 2021) 9.26 StyleGAN2 w/o ADA (Karras et al, 2020) 8.32 StyleGAN2 w/ ADA (Karras et al, 2020) 2.92 DDGAN (T=1) (Xiao et al, 2021) 16.68 DDGAN (Xiao et al, 2021) 3.75 RGM (Choi et al, 2023b) 2.47 Diffusion NCSN (Song & Ermon, 2019) 25.3 DDPM (Ho et al, 2020) 3.21 Score SDE (VE) (Song et al, 2021b) 2.20 Score SDE (VP) (Song et al, 2021b) 2.41 DDIM (50 steps) (Song et al, 2021a) 4.67 CLD (Dockhorn et al, 2022) 2.25 Subspace Diffusion (Jing et al, 2022) 2.17 LSGM (Vahdat et al, 2021) 2.10 VAE&EBM NVAE 23.5 Glow (Kingma & Dhariwal, 2018) 48.9 PixelCNN (Van Oord et al, 2016) 65.9 VAEBM (Xiao et al, 2020) 12.2 Recovery EBM (Gao et al, 2021) 9.58…”
Section: Ganmentioning
confidence: 99%